Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for BRG.OL and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for BRG.OL and 80,000+ other tickers.
See exactly how BRG.OL's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BRG.OL and 80,000+ other tickers.
Borregaard ASA, established in 2012 and headquartered in Sarpsborg, Norway, is a global enterprise focused on the development, production, and marketing of specialized biomaterials, biochemicals, and biofuels. Its market presence extends across Norway, the broader European region, the United States, Asia, and various other international territories. The company's operations are structured around three distinct divisions: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment provides biopolymers crucial for numerous applications, including agrochemicals, battery…
No recent news available.